Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity.
about
Critical questions in development of targeted nanoparticle therapeuticsMicromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regenerationTargeted Radionuclide Therapy of Human TumorsOverview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidMicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal CancersRecent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor TreatmentCyanine based Nanoprobes for Cancer Theranostics.Enhancing Tumor Penetration of Nanomedicines.Nanotubes-Embedded Indocyanine Green-Hyaluronic Acid Nanoparticles for Photoacoustic-Imaging-Guided Phototherapy.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceNanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.Porphyrin Nanodroplets: Sub-micrometer Ultrasound and Photoacoustic Contrast Imaging Agents.Photothermal enhancement of chemotherapy mediated by gold-silica nanoshell-loaded macrophages: in vitro squamous cell carcinoma study.Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releaseHighly Selective Photothermal Therapy by a Phenoxylated-Dextran-Functionalized Smart Carbon Nanotube Platform.Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.Cell Mediated Photothermal Therapy of Brain Tumors.In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.Molecular Imaging of Tumors Using a Quantitative T 1 Mapping Technique via Magnetic Resonance ImagingPOLYMERIC BIOMATERIALS AND NANOMEDICINES.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors.Polysaccharide-based nanoparticles for theranostic nanomedicine.CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing.Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor TherapyAn injectable nanoparticle generator enhances delivery of cancer therapeutics.Magnetic resonance imaging-guided stratified selection of patients for nano-therapy.Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Crossing the barrier: treatment of brain tumors using nanochain particles.pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer.Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells.Nanomedicines for renal disease: current status and future applicationsEnhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent.Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications.Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.
P2860
Q26751896-B9CA50D1-CF71-4931-B771-B762FC14E53EQ26765166-E9697A33-B888-4033-B3CD-A850803684E2Q26771267-DED96F9D-709C-4FC5-A627-CE1E8FA799FEQ26799981-A7AEB9E4-4B41-48CD-9663-5AA8F70143BFQ28076754-E234DC06-2073-424C-9971-C252B73E4C76Q28078974-3AE83290-C09F-47B6-BC1B-B250DE63DD2BQ30101038-51F77E01-006F-4199-81A9-590F8FE19A6FQ30356887-49F750A0-3670-4567-81FA-B5E33A55F83CQ30361945-082292F3-0221-4852-BEEE-5FD7F5533E53Q33759991-2FCA1155-D0E3-452F-9C3D-04FFD1FD8F98Q35767648-52205A37-1B2B-4411-8526-E38C8238FC72Q35860193-8D63D147-43D1-48E7-9AE8-B4B2AE78AB10Q35904558-A15CB71E-6236-47C8-9CFF-C22A1C5F7A78Q35912798-EBA6DF9B-4167-4CAF-A11A-EE89D3ED1D6AQ35974471-F4D4999E-86C1-4053-9363-D0843DEE2A99Q35975280-6A1DB44F-B514-4297-AB4C-2323D41C6FB9Q36049529-04234802-C983-4A05-9B20-C67567160A8EQ36051101-D5F5ECCC-7FA6-423A-9182-9B9F6650B5ABQ36108211-8ACFCA0D-AFB2-4602-8446-A687AC39EDCEQ36376467-E1F941BB-64FC-4F78-A3A8-17749E703CC1Q36395999-DDBE7C56-E1AA-422E-8C18-83FCFFA1694DQ36596242-F2E4ED8A-5FD2-408E-B495-5E0738901A68Q36703343-50181178-AC7F-489D-BE84-7459A303F739Q36802373-BBD135E0-885D-4897-87C4-6B12B879E32FQ36882942-4630C383-4EBE-4299-9845-8DD0AB158A8FQ37351049-FF65705A-38DD-43F8-9CFF-B0C1DDBB051DQ37407852-5CC5D332-6B2A-4A49-9B45-DC03743D1A5BQ37553428-1DDBAA29-C4F6-4C19-8DFE-9BE3F5DA478EQ38512169-0FB25780-CFFA-4812-B3ED-A255E30A4F64Q38559666-2D4C6413-788B-45CB-A478-EF52DC3B22DFQ38626421-C0F8D773-0617-422C-A199-2F4297A72BBDQ38676164-523BA2DF-E139-4373-9EB7-66074E52D2DBQ38691508-D883269C-B36A-4DA8-8DCD-20CF3FC8026DQ38694640-2D04950F-4CEE-431B-8F38-C41799613FFBQ38697217-73099E3A-CD55-44C9-BC89-B3E51DE12F51Q38697472-E9A7EC94-2649-4160-BAD0-72EFBB1C173BQ38802375-19246AD6-A4C7-4494-9975-7C0A0B790EBAQ38830847-01A7B0BC-A94A-4776-A792-8A4069EBDBB7Q38851214-46A84381-1AB2-4488-BD9B-34D47C5A935DQ38910806-6CCF6EA2-06F5-49C9-9838-2648F76C891E
P2860
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Toward a full understanding of ...... related to its heterogeneity.
@en
type
label
Toward a full understanding of ...... related to its heterogeneity.
@en
prefLabel
Toward a full understanding of ...... related to its heterogeneity.
@en
P1476
Toward a full understanding of ...... related to its heterogeneity.
@en
P2093
Hiroshi Maeda
P356
10.1016/J.ADDR.2015.01.002
P407
P577
2015-01-08T00:00:00Z